Skip to main content
. 2021 Jan 11;115(9):1061–1065. doi: 10.1093/trstmh/traa188

Table 3.

Adverse events observed in MDR/RR-TB patients on treatment

Adverse events Frequency Percentage
Gastrointestinal
 Nausea 14 8.3
 Vomiting 28 16.7
 Loss of appetite 6 3.7
Sensory
 Tinnitus 11 6.7
 Loss of hearing 7 4.3
 Numbness 7 4.3
 Blurred vision 2 1.2
Psychiatric
 Insomnia 15 9.1
 Psychosis 1 0.6
Skin
 Itching 8 4.9
 Rashes 7 4.3
Musculoskeletal
 Joint pain 31 18.9
Endocrine
 Swollen neck 1 0.6
Systemic
 Dizziness 5 3.0
 Fatigue 15 9.1
 Respiratory 6 3.7
 Chest pain 6 3.7
 Total 164 100